BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38329773)

  • 1. Mature plasmacytoid dendritic cell proliferation in association with mixed-phenotype acute leukemia, T/myeloid.
    Qiu L; Naresh KN
    Blood; 2024 Feb; 143(6):561. PubMed ID: 38329773
    [No Abstract]   [Full Text] [Related]  

  • 2. A Case Report of Mixed Phenotype Acute Leukemia with Plasmacytoid Dendritic Cell Proliferation.
    Li R; Zhang X; Xu L; Li H
    Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics and Diagnosis of Acute Myeloid Leukemia with CD56-Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Zhang X; Wu Y; Li C; Shen K; Li R
    Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow Cytometry Identifies a Spectrum of Maturation in Myeloid Neoplasms Having Plasmacytoid Dendritic Cell Differentiation.
    Hamadeh F; Awadallah A; Meyerson HJ; Beck RC
    Cytometry B Clin Cytom; 2020 Jan; 98(1):43-51. PubMed ID: 30614203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmacytoid Dendritic Cells, a Novel Target in Myeloid Neoplasms.
    Roussel X; Garnache Ottou F; Renosi F
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoplasms derived from plasmacytoid dendritic cells.
    Facchetti F; Cigognetti M; Fisogni S; Rossi G; Lonardi S; Vermi W
    Mod Pathol; 2016 Feb; 29(2):98-111. PubMed ID: 26743477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early T-cell precursor lymphoblastic leukemia accompanied by prominent blastic plasmacytoid dendritic cell proliferation mimicking blastic plasmacytoid dendritic cell neoplasm: an exceptional case report and literature review.
    Liao H; Yu J; Liu Y; Zhao S; Zhu H; Xu D; Jiang N; Zheng Q
    J Cancer Res Clin Oncol; 2022 Oct; 148(10):2911-2919. PubMed ID: 35933443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia.
    Song J; Li W; Bai Y; Zhou P; Niu J; Niu X; Liu Y; Liu X; Drokow EK; Sun K; Zhou H
    Ann Hematol; 2024 Feb; 103(2):463-473. PubMed ID: 38183444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. THERAPY-RELATED T/MYELOID MIXED PHENOTYPE ACUTE LEUKEMIA IN A PATIENT TREATED WITH CHEMOTHERAPY FOR CUTANEOUS DIFFUSE LARGE B CELL LYMPHOMA.
    Roberts E; Oncale M; Safah H; Schmieg J
    J La State Med Soc; 2016; 168(1):16-20. PubMed ID: 26986862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmacytoid dendritic cells in the setting of myeloid neoplasms: Diagnostic guide to challenging pathologic presentations.
    El Hussein S; Wang W
    Br J Haematol; 2023 Mar; 200(5):545-555. PubMed ID: 36606610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
    Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
    J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
    Curti A; Trabanelli S; Onofri C; Aluigi M; Salvestrini V; Ocadlikova D; Evangelisti C; Rutella S; De Cristofaro R; Ottaviani E; Baccarani M; Lemoli RM
    Haematologica; 2010 Dec; 95(12):2022-30. PubMed ID: 20801903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid Neoplasms with Elevated Plasmacytoid Dendritic Cell Differentiation Reflect the Maturation Process of Dendritic Cells.
    Huang Y; Wang Y; Chang Y; Yuan X; Hao L; Shi H; Lai Y; Huang X; Liu Y
    Cytometry A; 2020 Jan; 97(1):61-69. PubMed ID: 31876105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmacytoid dendritic cell expansion in myeloid neoplasms: A novel distinct subset of myeloid neoplasm?
    Peng J; He S; Yang X; Huang L; Wei J
    Crit Rev Oncol Hematol; 2023 Dec; 192():104186. PubMed ID: 37863402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mature plasmacytoid dendritic cells associated with acute myeloid leukemia show similar genetic mutations and expression profiles to leukemia cells.
    Gong X; Li C; Wang Y; Rao Q; Mi Y; Wang M; Wei H; Wang J
    Blood Sci; 2022 Jan; 4(1):38-43. PubMed ID: 35399539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm.
    Dargent JL; Delannoy A; Pieron P; Husson B; Debecker C; Petrella T
    J Cutan Pathol; 2011 Nov; 38(11):893-8. PubMed ID: 21883371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape.
    Zalmaï L; Viailly PJ; Biichle S; Cheok M; Soret L; Angelot-Delettre F; Petrella T; Collonge-Rame MA; Seilles E; Geffroy S; Deconinck E; Daguindau E; Bouyer S; Dindinaud E; Baunin V; Le Garff-Tavernier M; Roos-Weil D; Wagner-Ballon O; Salaun V; Feuillard J; Brun S; Drenou B; Mayeur-Rousse C; Okamba P; Dorvaux V; Tichionni M; Rose J; Rubio MT; Jacob MC; Raggueneau V; Preudhomme C; Saas P; Ferrand C; Adotevi O; Roumier C; Jardin F; Garnache-Ottou F; Renosi F
    Haematologica; 2021 Dec; 106(12):3056-3066. PubMed ID: 33054115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review.
    Shi Y; Wang E
    Arch Pathol Lab Med; 2014 Apr; 138(4):564-9. PubMed ID: 24678689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia.
    Xiao W; Goldberg AD; Famulare CA; Devlin SM; Nguyen NT; Sim S; Kabel CC; Patel MA; McGovern EM; Patel A; Schulman J; Dunbar AJ; Epstein-Peterson ZD; Menghrajani KN; Getta BM; Cai SF; Geyer MB; Glass JL; Taylor J; Viny AD; Levine RL; Zhang Y; Giralt SA; Klimek V; Tallman MS; Roshal M
    Haematologica; 2019 Jul; 104(7):1378-1387. PubMed ID: 30523054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T Lymphoblastic Lymphoma Hiding in Mature Plasmacytoid Dendritic Cell Proliferation: A Case Report and Literature Review.
    Deng C; Gao B; Wang T; Chang X; Xiao G; Xia Q; Pan H; Nie X
    Diagnostics (Basel); 2023 Oct; 13(20):. PubMed ID: 37892069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.